Type 2 Diabetes Mellitus
Conditions
Interventions
Control group:lifestyle intervention
Treatment group:Cofrogliptin tablets
Sponsors
The Second Clinical Medical College of Jilin University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age 18 years old or above; 2. Meets the diagnostic criteria for type 2 diabetes; 3. After the patient achieves the target of intensified treatment (normalization of blood sugar (fasting or pre-meal blood glucose < 6.5 mmol/L, and 2-hour post-meal blood glucose < 8.0 mmol/L)), screening will be conducted immediately. 4. Capable of understanding and voluntarily signing the written informed consent form.
Exclusion criteria
Exclusion criteria: 1. Exclude those with progressive central nervous system diseases, severe heart, lung, liver or kidney disorders; 2. Those who are allergic to the active ingredients or any excipients contained in repaglinide are prohibited from using it. 3. Excluding pregnant or lactating women; 4. Excluding patients who participated in another clinical study within 30 days prior to the baseline visit (using any investigational drugs or medical devices), participation in observational studies is permitted. 5. Exclude situations where the researchers make judgments about other factors that might affect the conduct of the clinical study and the interpretation of the research results.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 2-hour postprandial blood glucose (2hPG);fasting blood glucose (FBG);Fasting C-peptide (FCP);Fasting insulin (FINS); | — |
Primary
| Measure | Time frame |
|---|---|
| glycated hemoglobin (GHB); | — |
Countries
China
Contacts
Public ContactWang Yanjun
The Second Clinical Medical College of Jilin University
Outcome results
None listed